RANI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Rani Therapeutics Holdings Inc

Watchlist Manager

Watchlist

Price: 0.843 USD 2.55%

Market Cap: $114.9m

	Rani Therapeutics Holdings Inc NASDAQ:RANI	US
	FG Nexus Inc F:LU5	US
	Secure Energy Services Inc TSX:SES	CA
	Leonteq AG F:EFL	CH
C	China Longyuan Power Group Corp Ltd F:6WX	CN
	Strategic Metals Ltd XTSX:SMD	CA
	OMV AG F:OMVI	AT
S	SoftOx Solutions AS OSE:SOFTX	NO
	Creative Realities Inc NASDAQ:CREX	US
H	Honda Motor Co Ltd OTC:HNDAF	JP
	Capricor Therapeutics Inc F:4LN2	US

Profitability Summary

Rani Therapeutics Holdings Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-688%

Negative 3Y Average Operating Margin

-3 011%

Negative Net Margin

-618%

Negative 3Y Average Net Margin

-1 943%

Negative Free Cash Flow Margin

-417%

Negative 3Y Average Free Cash Flow Margin

Negative 3Y Average ROIC

-598%

ROIC is Increasing

-1 015% > -594%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.